Germany· DE-A57-01255be696c20043
Spiolto Respimat
A medicinal product containing tiotropium, olodaterol, registered in Germany by Boehringer Ingelheim International Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Tiotropium, Olodaterol
- Manufacturer
- Boehringer Ingelheim International Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tiotropium, olodaterol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSPIOLTO RESPIMATBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- NetherlandsSpiolto Respimat 2,5 microgram/2,5 microgram, inhalatieoplossingBoehringer Ingelheim International GmbH
- SpainSPIOLTO RESPIMAT 2,5 MICROGRAMOS / 2,5 MICROGRAMOS SOLUCION PARA INHALACIONBoehringer Ingelheim International Gmbh
- IrelandSpiolto Respimat 2.5 microgram/2.5 microgram, inhalation solutionBoehringer Ingelheim International GmbH
- United KingdomSpiolto Respimat 2.5micrograms/dose / 2.5micrograms/dose inhalation solution cartridge with deviceBoehringer Ingelheim Ltd
- FinlandInspiolto RespimatBoehringer Ingelheim International GmbH
- SwitzerlandSpiolto Respimat 2.5 mcg / 2.5 mcg, Lösung zur Inhalation (wiederverwendbar)Boehringer Ingelheim (Schweiz) GmbH
- PolandSpiolto RespimatBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Spiolto Respimat, Yanimo Respimat
- Belgium · Spiolto Respimat, Yanimo Respimat
- Bulgaria · Спиолто Респимат, Янимо Респимат
- Cyprus · Spiolto Respimat, Yanimo Respimat
- Czechia · Spiolto Respimat
- Denmark · Spiolto Respimat
- Estonia · Spiolto Respimat
- Spain · Spiolto Respimat, Yanimo Respimat
- Finland · Inspiolto Respimat, Yanimo Respimat
- France · Spiolto Respimat
- United Kingdom (Northern Ireland) · Spiolto Respimat
- Greece · Spiolto Respimat, Yanimo Respimat
- Croatia · Spiolto Respimat
- Hungary · Spiolto Respimat
- Ireland · Spiolto Respimat
- Iceland · Spiolto Respimat
- Italy · Spiolto Respimat
- Liechtenstein · Spiolto Respimat, Yanimo Respimat
- Lithuania · Spiolto Respimat
- Luxembourg · Spiolto Respimat, Yanimo Respimat
- Latvia · Spiolto Respimat
- Malta · Spiolto Respimat
- Netherlands · Spiolto Respimat, Yanimo Respimat
- Norway · Spiolto Respimat
- Poland · Spiolto Respimat, Yanimo Respimat
- Portugal · Spiolto Respimat, Yanimo Respimat
- Romania · Spiolto Respimat
- Sweden · Spiolto Respimat, Yanimo Respimat
- Slovenia · Spiolto Respimat
- Slovakia · Spiolto Respimat
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2dbf811-9008-47d9-b1df-5e2e1cb724f4 GET /v1/drugs/a2dbf811-9008-47d9-b1df-5e2e1cb724f4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Inhalation Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Tiotropium, Olodaterol",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about tiotropium, olodaterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.